Prophylactic pegfilgrastim to prevent febrile neutropenia among patients receiving biweekly (Q2W) chemotherapy regimens: a systematic review of efficacy, effectiveness and safety
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prophylactic pegfilgrastim to prevent febrile neutropenia among patients receiving biweekly (Q2W) chemotherapy regimens: a systematic review of efficacy, effectiveness and safety ; volume:21 ; number:1 ; day:27 ; month:5 ; year:2021 ; pages:1-19 ; date:12.2021
BMC cancer ; 21, Heft 1 (27.5.2021), 1-19, 12.2021
- Creator
-
Mahtani, Reshma
Crawford, Jeffrey
Flannery, Sinéad M.
Lawrence, Tatiana
Schenfeld, Jennifer
Gawade, Prasad L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-021-08258-w
- URN
-
urn:nbn:de:101:1-2021092319541979436257
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mahtani, Reshma
- Crawford, Jeffrey
- Flannery, Sinéad M.
- Lawrence, Tatiana
- Schenfeld, Jennifer
- Gawade, Prasad L.
- SpringerLink (Online service)
Other Objects (12)
Febrile neutropenia : with 32 tables
The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma
Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients (Review)
Chemotherapy and febrile neutropenia - diagnostic and therapeutic management
Antimicrobial stewardship in high-risk febrile neutropenia patients
Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC: post hoc analysis from NEJ051
Assessment of Chemotherapy-Induced Febrile Neutropenia in Cancer Patients
Diagnostics and therapy of paediatric patients with febrile neutropenia
Safety and tolerability of Peg-grafeel™, a pegfilgrastim, for the prophylactic treatment of chemotherapy-induced neutropenia and febrile neutropenia: A prospective, observational, postmarketing surveillance study in India
Prophylactic antibiotic regimens in tumor surgery (PARITY) survey
Bacterial infection profiles in lung cancer patients with febrile neutropenia
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Febrile neutropenia : with 32 tables
The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma
Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients (Review)
Chemotherapy and febrile neutropenia - diagnostic and therapeutic management
Antimicrobial stewardship in high-risk febrile neutropenia patients
Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC: post hoc analysis from NEJ051
Assessment of Chemotherapy-Induced Febrile Neutropenia in Cancer Patients
Diagnostics and therapy of paediatric patients with febrile neutropenia
Safety and tolerability of Peg-grafeel™, a pegfilgrastim, for the prophylactic treatment of chemotherapy-induced neutropenia and febrile neutropenia: A prospective, observational, postmarketing surveillance study in India
Prophylactic antibiotic regimens in tumor surgery (PARITY) survey
Bacterial infection profiles in lung cancer patients with febrile neutropenia
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Febrile neutropenia : with 32 tables
The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma
Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients (Review)
Chemotherapy and febrile neutropenia - diagnostic and therapeutic management
Antimicrobial stewardship in high-risk febrile neutropenia patients
Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC: post hoc analysis from NEJ051
Assessment of Chemotherapy-Induced Febrile Neutropenia in Cancer Patients
Diagnostics and therapy of paediatric patients with febrile neutropenia
Safety and tolerability of Peg-grafeel™, a pegfilgrastim, for the prophylactic treatment of chemotherapy-induced neutropenia and febrile neutropenia: A prospective, observational, postmarketing surveillance study in India
Prophylactic antibiotic regimens in tumor surgery (PARITY) survey
Bacterial infection profiles in lung cancer patients with febrile neutropenia